Although clinical trials of antibodies against TSLP/TSLPR have been successful in treating asthma,42 but not yet in AD,43 the beneficial role of TSLP/TSLPR blockage in treating itch and AD cannot be fully excluded. The gene discussed is TSLP; the disease is Alzheimer disease.